Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. (Q31037255)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. |
scientific article |
Statements
1 reference
Peroral amphotericin B polymer nanoparticles lead to comparable or superior in vivo antifungal activity to that of intravenous Ambisome® or Fungizone™. (English)
1 reference
Jagdishbhai L Italia
1 reference
Andrew Sharp
1 reference
Katharine C Carter
1 reference
Peter Warn
1 reference
M N V Ravi Kumar
1 reference
6 October 2011
1 reference
1 reference
10
1 reference
e25744
1 reference
6 October 2011
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference